The treatment of skin immune diseases is one of the most successful cases in immunological translational medicine. Previously, the treatment of skin immune diseases was mainly achieved through accidental discovery of drugs or therapies, often with poor efficacy and certain toxicity during long-term treatment. With the application of biological agents, more and more patients are achieving the treatment goal of complete or almost complete clearance of skin lesions and itching. We still have many questions regarding the pharmaceutical mechanisms of biological agents, rational and safe use of drugs, long-term patient management, and early intervention. In order to promote the development of skin immune diseases, psoriasis, urticaria and other fields, improve the level of precision diagnosis and treatment, use biological agents reasonably and safely, manage chronic diseases throughout the process, and reduce the disease burden of patients, the Chengdu High tech Medical Association hosted the Chengdu High tech Medical Association Skin Disease and Beauty Credit Committee, and organized the Chengdu High tech Medical Association Skin Disease and Beauty Credit Committee, the Chengdu High tech Medical Association Skin Disease and Beauty Credit Committee Disruptive Disease Academic Conference was held online on September 26, 2023, More than ten experts and scholars from Sichuan Provincial People's Hospital, including Professor Chen Xuejun, Professor Chen Jin, Professor Lin Xinyu, and Professor Lu Yonghong from Chengdu Second People's Hospital, were invited to give wonderful lectures on relevant topics. The attending representatives expressed their great benefits and hoped to participate in similar conferences in the future.